Approval · Notice of Compliance 23145 · 2020
ELTROXIN: Notice of Compliance 23145
Issued January 27, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23145
- Date
- January 27, 2020
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing site and labelling chage
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELTROXIN | Not yet assigned | — |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB